skip to content

Read about our recent product expansion here.

News & Articles

Full Transcript: Lindsay Avner, Founder and CEO of Bright Pink, on Sequenced

Linda Jiang

On this episode of Sequenced, we talk to Lindsay Avner, Founder and CEO of Bright Pink. Lindsay underwent genetic testing at age 22. The test revealed she carried a mutation on the BRCA1 gene. At 23, she became the youngest woman in the U.S. to undergo a risk-reducing double mastectomy. Lindsay shares her commitment to live proactively, why she founded Bright Pink, and how women can be advocates for their own health.

We’ve posted complete transcript of the podcast below. You can subscribe to Sequenced on Apple Podcasts, SoundCloud, Stitcher, and Google Play.

Bright Pink is a national non-profit organization that focuses on saving women’s lives from breast and ovarian cancer by empowering them to live proactively at a young age. Bright Pink offers interactive digital tools to help women assess their risk for breast and ovarian cancer (assessyourrisk.org) and address their questions around genetic testing (exploreyourgenetics.org).

Genomics

How 30,000 People Took More Control of Their Health: A Milestone in Accessible Personalized Medicine

Hairless woman portrait at home looking through the window with folded arms waiting for coffee.
Genomics

Too few cancer patients receive genetic testing—after they’ve been diagnosed